Shares of Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 26.50 ($0.33) and traded as low as GBX 26 ($0.33). Mereo BioPharma Group plc (MPH.L) shares last traded at GBX 26.50 ($0.33), with a volume of 49,264 shares.
Mereo BioPharma Group plc (MPH.L) Trading Down 1.9 %
The company has a debt-to-equity ratio of 164.26, a quick ratio of 2.92 and a current ratio of 2.98. The company’s 50 day moving average is GBX 26.50 and its 200 day moving average is GBX 26.50. The stock has a market capitalization of £89.76 million and a price-to-earnings ratio of -0.21.
Mereo BioPharma Group plc (MPH.L) Company Profile
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Featured Stories
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- Financial Services Stocks Investing
- MarketBeat Week in Review – 4/29 – 5/3
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- CD Calculator: Certificate of Deposit Calculator
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
